FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2044486670> ?p ?o ?g. }

• W2044486670 endingPage "860" @default.
• W2044486670 startingPage "850" @default.
• W2044486670 abstract "Abstract Aims It has been reported that glucagon‐like peptide‐1 ( GLP ‐1) agents are associated with an increased risk of pancreatic cancer in patients with type 2 diabetes. Reports have indicated that GLP ‐1 promotes pancreatic metaplasia and premalignant lesions. The aims of this study were to determine the effects of GLP ‐1‐based therapy on pancreatic cancer cells. Methods Immunohistochemistry was used to investigate GLP ‐1 receptor ( GLP‐1R ) expression in 30 human pancreatic cancer tissues. We also analysed associated clinicopathological data and each patient's prognosis. Two human pancreatic cancer cell lines were used to evaluate the in vitro effects of the GLP‐1R agonist liraglutide on cell growth, migration and invasion. Mouse xenograft models of human pancreatic cancer were established to evaluate the effects of liraglutide in vivo . Results Human pancreatic cancer tissues showed lower levels or a lack of GLP‐1R expression when compared with levels in the tumour‐adjacent pancreatic tissues. Negative GLP‐1R expression occurred more frequently in advanced tumours with larger diameters and lymphatic metastasis, and was associated with a poor prognosis. GLP‐1R activation with liraglutide inhibited tumourigenicity and metastasis of human pancreatic cancer cells in vitro and in vivo . Akt activation was dose‐dependently inhibited by liraglutide, and the PI3K inhibitors, LY294002 and wortmannin, displayed similar suppressive effects to liraglutide in human pancreatic cancer cells. Conclusions GLP‐1R activation has an antitumour effect on human pancreatic cancers via inhibition of the PI3K /Akt pathway. This finding suggests that GLP ‐1‐based therapies may be beneficial, rather than harmful, in treating type 2 diabetic patients with pancreatic cancer." @default.
• W2044486670 created "2016-06-24" @default.
• W2044486670 creator A5006301048 @default.
• W2044486670 creator A5009771110 @default.
• W2044486670 creator A5019377029 @default.
• W2044486670 creator A5019872937 @default.
• W2044486670 creator A5020237838 @default.
• W2044486670 creator A5043219536 @default.
• W2044486670 creator A5044329598 @default.
• W2044486670 creator A5050887292 @default.
• W2044486670 creator A5081851067 @default.
• W2044486670 date "2014-04-15" @default.
• W2044486670 modified "2023-10-05" @default.
• W2044486670 title "Activation of glucagon-like peptide-1 receptor inhibits tumourigenicity and metastasis of human pancreatic cancer cells via PI3K/Akt pathway" @default.
• W2044486670 cites W146600679 @default.
• W2044486670 cites W1545460826 @default.
• W2044486670 cites W1572960859 @default.
• W2044486670 cites W1968483633 @default.
• W2044486670 cites W1975663485 @default.
• W2044486670 cites W1980884563 @default.
• W2044486670 cites W1993863128 @default.
• W2044486670 cites W2018939316 @default.
• W2044486670 cites W2019214567 @default.
• W2044486670 cites W2021852198 @default.
• W2044486670 cites W2023644010 @default.
• W2044486670 cites W2031848004 @default.
• W2044486670 cites W2047318784 @default.
• W2044486670 cites W2049717993 @default.
• W2044486670 cites W2051478811 @default.
• W2044486670 cites W2064130493 @default.
• W2044486670 cites W2077082351 @default.
• W2044486670 cites W2086690729 @default.
• W2044486670 cites W2091323994 @default.
• W2044486670 cites W2098008729 @default.
• W2044486670 cites W2100991539 @default.
• W2044486670 cites W2107370002 @default.
• W2044486670 cites W2112981414 @default.
• W2044486670 cites W2114866762 @default.
• W2044486670 cites W2115357902 @default.
• W2044486670 cites W2116339973 @default.
• W2044486670 cites W2120069833 @default.
• W2044486670 cites W2122696108 @default.
• W2044486670 cites W2127854619 @default.
• W2044486670 cites W2129405414 @default.
• W2044486670 cites W2136840982 @default.
• W2044486670 cites W2137982063 @default.
• W2044486670 cites W2138091232 @default.
• W2044486670 cites W2140004965 @default.
• W2044486670 cites W2140536043 @default.
• W2044486670 cites W2155500946 @default.
• W2044486670 cites W2160474387 @default.
• W2044486670 cites W2165948908 @default.
• W2044486670 cites W2170598577 @default.
• W2044486670 cites W4211208840 @default.
• W2044486670 doi "https://doi.org/10.1111/dom.12291" @default.
• W2044486670 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24641303" @default.
• W2044486670 hasPublicationYear "2014" @default.
• W2044486670 type Work @default.
• W2044486670 sameAs 2044486670 @default.
• W2044486670 citedByCount "38" @default.
• W2044486670 countsByYear W20444866702014 @default.
• W2044486670 countsByYear W20444866702015 @default.
• W2044486670 countsByYear W20444866702016 @default.
• W2044486670 countsByYear W20444866702017 @default.
• W2044486670 countsByYear W20444866702018 @default.
• W2044486670 countsByYear W20444866702019 @default.
• W2044486670 countsByYear W20444866702020 @default.
• W2044486670 countsByYear W20444866702021 @default.
• W2044486670 countsByYear W20444866702022 @default.
• W2044486670 countsByYear W20444866702023 @default.
• W2044486670 crossrefType "journal-article" @default.
• W2044486670 hasAuthorship W2044486670A5006301048 @default.
• W2044486670 hasAuthorship W2044486670A5009771110 @default.
• W2044486670 hasAuthorship W2044486670A5019377029 @default.
• W2044486670 hasAuthorship W2044486670A5019872937 @default.
• W2044486670 hasAuthorship W2044486670A5020237838 @default.
• W2044486670 hasAuthorship W2044486670A5043219536 @default.
• W2044486670 hasAuthorship W2044486670A5044329598 @default.
• W2044486670 hasAuthorship W2044486670A5050887292 @default.
• W2044486670 hasAuthorship W2044486670A5081851067 @default.
• W2044486670 hasConcept C121608353 @default.
• W2044486670 hasConcept C126322002 @default.
• W2044486670 hasConcept C134018914 @default.
• W2044486670 hasConcept C144369459 @default.
• W2044486670 hasConcept C150903083 @default.
• W2044486670 hasConcept C170493617 @default.
• W2044486670 hasConcept C185280430 @default.
• W2044486670 hasConcept C207001950 @default.
• W2044486670 hasConcept C2777180221 @default.
• W2044486670 hasConcept C2778938600 @default.
• W2044486670 hasConcept C2779013556 @default.
• W2044486670 hasConcept C2780210213 @default.
• W2044486670 hasConcept C2781308992 @default.
• W2044486670 hasConcept C502942594 @default.
• W2044486670 hasConcept C555293320 @default.
• W2044486670 hasConcept C62478195 @default.
• W2044486670 hasConcept C71924100 @default.
• W2044486670 hasConcept C75217442 @default.

• next